Predicting Joint Damage in Rheumatoid Arthritis with Serum Biomarkers
Author Information
Author(s): SMM Verstappen, AR Poole, M Ionescu, LE King, M Abrahamowicz, DM Hofman, JWJ Bijlsma, FPJG Lafeber
Primary Institution: University Medical Center Utrecht, The Netherlands
Hypothesis
Serum biomarkers for cartilage degradation and synthesis can predict radiographic damage in rheumatoid arthritis patients.
Conclusion
The study found that serum biomarkers related to cartilage breakdown are associated with joint destruction in rheumatoid arthritis and can help predict disease progression.
Supporting Evidence
- Patients with rapid radiographic progression had higher levels of C2C, C1,2C, and CS846-epitope compared to slow progressors.
- C2C levels at year 1 can predict long-term radiographic progression.
- C2C was a significant predictor for joint space narrowing and annual radiographic damage.
Takeaway
Doctors can use certain blood tests to see if a patient's arthritis is getting worse, which helps them treat the patient better.
Methodology
The study analyzed clinical and radiographic data of 87 RA patients over four years, measuring serum concentrations of four cartilage biomarkers annually.
Potential Biases
Potential bias due to the non-randomized nature of treatment assignment and the observational design.
Limitations
The study did not control for the influence of treatment on biomarker levels and focused on a specific cohort.
Participant Demographics
Mean age of participants was 58 years, with 63% being female.
Statistical Information
P-Value
0.030
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website